Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA to Convene Pharmacy Compounding Advisory Committee in July Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York